TransMedics Group (NASDAQ:TMDX) First Quarter 2024 Results Key Financial Results Revenue: US$96.9m (up 133% from 1Q 2023). Net income: US$12.2m (up from US$2.64m loss in 1Q 2023). Profit margin: 13% ...
Source LinkTransMedics Group (NASDAQ:TMDX) First Quarter 2024 Results Key Financial Results Revenue: US$96.9m (up 133% from 1Q 2023). Net income: US$12.2m (up from US$2.64m loss in 1Q 2023). Profit margin: 13% ...
Source Link
Comments